Cargando…

D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity

BACKGROUND: Dysregulation of N-methyl D-aspartate (NMDA) receptor signaling is strongly implicated in schizophrenia. Based on the ketamine model of NMDA receptor hypoactivity, therapeutic approaches designed to maintain a sustained increase in agonist activity at the glycine site of the NMDA recepto...

Descripción completa

Detalles Bibliográficos
Autor principal:	Goff, Donald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327448/ https://www.ncbi.nlm.nih.gov/pubmed/26915421 http://dx.doi.org/10.2174/1570159X14666160225154812

Ejemplares similares

D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
por: Hofmann, Stefan G, et al.
Publicado: (2013)

The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model
por: Yao, Lulu, et al.
Publicado: (2019)

D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome
por: Na, Elisa S., et al.
Publicado: (2017)

Cycloserine induced mania
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder
por: Wink, Logan K., et al.
Publicado: (2017)

The NMDA receptor partial agonist d-cycloserine does not enhance motor learning
por: Günthner, Jan, et al.
Publicado: (2016)

D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach
por: MacKillop, J, et al.
Publicado: (2015)

Correction: D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome
por: Na, Elisa S., et al.
Publicado: (2018)

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
por: Schade, Sebastian, et al.
Publicado: (2015)

d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition
por: de Chiara, Cesira, et al.
Publicado: (2020)

A randomized pharmacological fMRI trial investigating d-cycloserine and brain plasticity mechanisms in learned pain responses
por: Thomaidou, Mia A., et al.
Publicado: (2022)

Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis
por: Rodrigues, Helga, et al.
Publicado: (2014)

Cycloserine induced psychosis with hepatic dysfunction
por: Tandon, Vishal R., et al.
Publicado: (2015)

The NMDA Agonist D-Cycloserine Facilitates Fear Memory Consolidation in Humans
por: Kalisch, Raffael, et al.
Publicado: (2009)

Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance
por: Nakatani, Yoshio, et al.
Publicado: (2017)

Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder
por: Hofmann, Stefan G., et al.
Publicado: (2019)

Reinterpreting the Mechanism of Inhibition of Mycobacterium tuberculosisd-Alanine:d-Alanine Ligase by d-Cycloserine
por: Prosser, Gareth A., et al.
Publicado: (2013)

Neuroleptic malignant syndrome in cycloserine-induced psychosis
por: Sawant, Neena S., et al.
Publicado: (2015)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
por: Alghamdi, Wael A., et al.
Publicado: (2019)

Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium
por: Wang, Ruibai, et al.
Publicado: (2022)

Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis
por: Prosser, Gareth A., et al.
Publicado: (2013)

Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD
por: Inslicht, Sabra S., et al.
Publicado: (2021)

D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents
por: Farrell, Lara J., et al.
Publicado: (2018)

Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine
por: LeVine, Steven M., et al.
Publicado: (2022)

The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans
por: Nottage, J. F., et al.
Publicado: (2022)

Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine
por: Batson, Sarah, et al.
Publicado: (2017)

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders
por: Minshawi, Noha F., et al.
Publicado: (2016)

Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke
por: Butler, Andrew J., et al.
Publicado: (2015)

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
por: Desjardins, Christopher A., et al.
Publicado: (2016)

A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder
por: Breitborde, Nicholas JK, et al.
Publicado: (2014)

Correction to Reinterpreting the Mechanism of Inhibition of Mycobacterium tuberculosisd-Alanine:d-Alanine Ligase by d-Cycloserine
por: Prosser, Gareth A., et al.
Publicado: (2013)

D-cycloserine in Prelimbic Cortex Reverses Scopolamine-Induced Deficits in Olfactory Memory in Rats
por: Portero-Tresserra, Marta, et al.
Publicado: (2013)

Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study
por: Takiguchi, Kazuo, et al.
Publicado: (2017)

D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis
por: Xia, Jing, et al.
Publicado: (2015)

Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial
por: Smits, Jasper A. J., et al.
Publicado: (2020)

PM470. Structural and functional brain alterations in schizophrenia patients treated with D-cycloserine: A combination of VBM and resting-state functional connectivity study
por: Ohta, Masashi, et al.
Publicado: (2016)

Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine
por: Dempsey-Jones, Harriet, et al.
Publicado: (2021)

Structure of the d-Cycloserine-Resistant Variant D322N of Alanine Racemase from Mycobacterium tuberculosis
por: de Chiara, Cesira, et al.
Publicado: (2023)

D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis
por: Bürkner, Paul-Christian, et al.
Publicado: (2017)

Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight
por: Chaturvedi, Sumit Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9t4nhe423n5e3tfo3tcmdiie66